Clinical Trials · NCT06598839

Immuno-effect of Tα1 for Stage I NSCLC

RecruitingN/AThymosin Alpha-1 (Investigational)
Phase
N/A
Recruitment status
Recruiting
Sponsor
Yousheng Mao
Enrollment
40
Start date
Jun 2024
Locations
1 site, China
Primary endpoint
Number of CTCs
View Thymosin-Alpha-1 compound reference